Molecular Weight:   | 256.04 |
Volume:   | 247.89 |
LogP:   | 2.726 |
LogD:   | 1.86 |
LogS:   | -4.044 |
# Rotatable Bonds:   | 0 |
TPSA:   | 91.67 |
# H-Bond Aceptor:   | 5 |
# H-Bond Donor:   | 2 |
# Rings:   | 3 |
# Heavy Atoms:   | 5 |
QED Drug-Likeness Score:   | 0.424 |
Synthetic Accessibility Score:   | 2.529 |
Fsp3:   | 0.071 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Accepted |
GSK Rule:   | Accepted |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 0 |
PAINS Alert:   | 2 |
Caco-2 Permeability:   | -4.894 |
MDCK Permeability:   | 1.6623525880277157e-05 |
Pgp-inhibitor:   | 0.059 |
Pgp-substrate:   | 0.0 |
Human Intestinal Absorption (HIA):   | 0.768 |
20% Bioavailability (F20%):   | 0.545 |
30% Bioavailability (F30%):   | 0.988 |
Blood-Brain-Barrier Penetration (BBB):   | 0.03 |
Plasma Protein Binding (PPB):   | 97.5836410522461% |
Volume Distribution (VD):   | 0.617 |
Pgp-substrate:   | 2.577989339828491% |
CYP1A2-inhibitor:   | 0.939 |
CYP1A2-substrate:   | 0.092 |
CYP2C19-inhibitor:   | 0.094 |
CYP2C19-substrate:   | 0.065 |
CYP2C9-inhibitor:   | 0.463 |
CYP2C9-substrate:   | 0.514 |
CYP2D6-inhibitor:   | 0.334 |
CYP2D6-substrate:   | 0.187 |
CYP3A4-inhibitor:   | 0.398 |
CYP3A4-substrate:   | 0.118 |
Clearance (CL):   | 6.371 |
Half-life (T1/2):   | 0.333 |
hERG Blockers:   | 0.019 |
Human Hepatotoxicity (H-HT):   | 0.089 |
Drug-inuced Liver Injury (DILI):   | 0.972 |
AMES Toxicity:   | 0.793 |
Rat Oral Acute Toxicity:   | 0.124 |
Maximum Recommended Daily Dose:   | 0.052 |
Skin Sensitization:   | 0.867 |
Carcinogencity:   | 0.595 |
Eye Corrosion:   | 0.011 |
Eye Irritation:   | 0.948 |
Respiratory Toxicity:   | 0.284 |
Natural Product ID:   | NPC238629 |
Common Name*:   | Purpurin |
IUPAC Name:   | 1,2,4-trihydroxyanthracene-9,10-dione |
Synonyms:   | 1,2,4-Trihydroxy-Anthraquinone; Purpurin |
Standard InCHIKey:   | BBNQQADTFFCFGB-UHFFFAOYSA-N |
Standard InCHI:   | InChI=1S/C14H8O5/c15-8-5-9(16)14(19)11-10(8)12(17)6-3-1-2-4-7(6)13(11)18/h1-5,15-16,19H |
SMILES:   | c1ccc2c(c1)C(=O)c1c(cc(c(c1C2=O)O)O)O |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL294264 |
PubChem CID:   |
6683 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO26542 | Rubia cordifolia | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[18078747] |
NPO19792 | Populus tomentosa | Species | Salicaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[22860454] |
NPO20880 | Conocybe siliginea | Species | Bolbitiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[32816486] |
NPO28159 | Rubia akane | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[8176404] |
NPO26542 | Rubia cordifolia | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[8882438] |
NPO29836 | Cassia obtusifolia | Species | Fabaceae | Eukaryota | n.a. | seed | n.a. |
PMID[9810700] |
NPO20881 | Rheum officinale | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO21199 | Alangium platanifolium | Species | Cornaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO19792 | Populus tomentosa | Species | Salicaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO10014 | Rubia tinctorum | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO26542 | Rubia cordifolia | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO29836 | Cassia obtusifolia | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO17395 | Asperula odorata | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO28024 | Rheum palmatum | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO7632 | Rheum tanguticum | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO19792 | Populus tomentosa | Species | Salicaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO26542 | Rubia cordifolia | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO21199 | Alangium platanifolium | Species | Cornaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO28024 | Rheum palmatum | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO20881 | Rheum officinale | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO7632 | Rheum tanguticum | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO10014 | Rubia tinctorum | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO20572 | Vepris louisii | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO17395 | Asperula odorata | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO29836 | Cassia obtusifolia | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO19792 | Populus tomentosa | Species | Salicaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO26542 | Rubia cordifolia | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO7632 | Rheum tanguticum | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO20881 | Rheum officinale | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO10014 | Rubia tinctorum | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO28024 | Rheum palmatum | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO17395 | Asperula odorata | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO28159 | Rubia akane | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO26542 | Rubia cordifolia | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO25238 | Rheum coreanum | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO28024 | Rheum palmatum | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO7632 | Rheum tanguticum | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO20881 | Rheum officinale | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO19792 | Populus tomentosa | Species | Salicaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO26542 | Rubia cordifolia | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO20881 | Rheum officinale | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO28024 | Rheum palmatum | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO20822 | Asperula odora | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO19956 | Pulveroboletus retipes | Species | Boletaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO20572 | Vepris louisii | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO20880 | Conocybe siliginea | Species | Bolbitiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO10014 | Rubia tinctorum | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO8020 | Lychnophora columnaris | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO20064 | Litsea konishii | Species | Lauraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25238 | Rheum coreanum | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO17395 | Asperula odorata | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO20364 | Ophelia bicornis | Species | Opheliidae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO21199 | Alangium platanifolium | Species | Cornaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO28159 | Rubia akane | Species | Rubiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO7632 | Rheum tanguticum | Species | Polygonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO15980 | Croton penduliflorus | Species | Euphorbiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT80 | Cell Line | Raji | Homo sapiens | Activity | > | 80.0 | % | PMID[556262] |
NPT80 | Cell Line | Raji | Homo sapiens | Activity | = | 70.0 | % | PMID[556262] |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 6309.6 | nM | PMID[556263] |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 3981.1 | nM | PMID[556264] |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 3162.3 | nM | PMID[556264] |
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 7943.3 | nM | PMID[556263] |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 15848.9 | nM | PMID[556264] |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 22387.2 | nM | PMID[556263] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 316.2 | nM | PMID[556263] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 12589.3 | nM | PMID[556264] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 14125.4 | nM | PMID[556263] |
NPT4033 | Individual Protein | Protein Rev | Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | IC50 | > | 75434.0 | nM | PMID[556265] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 5011.9 | nM | PMID[556264] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 5011.9 | nM | PMID[556263] |
NPT583 | Individual Protein | Inositol monophosphatase 1 | Rattus norvegicus | Potency | = | 10000.0 | nM | PMID[556264] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 28183.8 | nM | PMID[556263] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 22387.2 | nM | PMID[556264] |
NPT157 | Individual Protein | Breast cancer type 1 susceptibility protein | Homo sapiens | Potency | = | 39810.7 | nM | PMID[556264] |
NPT157 | Individual Protein | Breast cancer type 1 susceptibility protein | Homo sapiens | Potency | = | 39810.7 | nM | PMID[556263] |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 12589.3 | nM | PMID[556264] |
NPT1119 | Individual Protein | Arachidonate 12-lipoxygenase | Homo sapiens | Potency | = | 3548.1 | nM | PMID[556264] |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 31622.8 | nM | PMID[556263] |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 17740.7 | nM | PMID[556263] |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 19952.6 | nM | PMID[556264] |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 25118.9 | nM | PMID[556263] |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 28183.8 | nM | PMID[556264] |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 25118.9 | nM | PMID[556263] |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 39810.7 | nM | PMID[556264] |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | n.a. | 22387.2 | nM | PMID[556266] |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[556264] |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | n.a. | 7943.3 | nM | PMID[556263] |
NPT4035 | Individual Protein | Female germline-specific tumor suppressor gld-1 | Caenorhabditis elegans | IC50 | = | 6688.0 | nM | PMID[556265] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 50118.7 | nM | PMID[556264] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 35481.3 | nM | PMID[556263] |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | n.a. | 11220.2 | nM | PMID[556266] |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | n.a. | 50118.7 | nM | PMID[556266] |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | n.a. | 7079.5 | nM | PMID[556264] |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | n.a. | 3981.1 | nM | PMID[556263] |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | n.a. | 56234.1 | nM | PMID[556264] |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | n.a. | 25118.9 | nM | PMID[556263] |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | n.a. | 34673.69 | nM | PMID[556267] |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | n.a. | 27415.74 | nM | PMID[556267] |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | n.a. | 29922.65 | nM | PMID[556267] |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | n.a. | 18967.06 | nM | PMID[556267] |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | n.a. | 25234.81 | nM | PMID[556267] |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | n.a. | 24043.63 | nM | PMID[556267] |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | n.a. | 17823.79 | nM | PMID[556267] |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | n.a. | 37931.5 | nM | PMID[556267] |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | n.a. | 32734.07 | nM | PMID[556267] |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | n.a. | 36475.39 | nM | PMID[556267] |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | n.a. | 31045.6 | nM | PMID[556267] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | n.a. | 22438.82 | nM | PMID[556267] |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | n.a. | 34040.82 | nM | PMID[556267] |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | n.a. | 23713.74 | nM | PMID[556267] |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | n.a. | 35645.11 | nM | PMID[556267] |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | n.a. | 55462.57 | nM | PMID[556267] |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | n.a. | 80723.5 | nM | PMID[556267] |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | n.a. | 38106.58 | nM | PMID[556267] |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | n.a. | 34119.29 | nM | PMID[556267] |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | n.a. | 81283.05 | nM | PMID[556267] |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | n.a. | 40086.67 | nM | PMID[556267] |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | n.a. | 36728.23 | nM | PMID[556267] |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | n.a. | 41495.4 | nM | PMID[556267] |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | n.a. | 33573.76 | nM | PMID[556267] |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | n.a. | 22855.99 | nM | PMID[556267] |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | n.a. | 41304.75 | nM | PMID[556267] |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | n.a. | 43551.19 | nM | PMID[556267] |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | n.a. | 25822.6 | nM | PMID[556267] |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | n.a. | 41020.41 | nM | PMID[556267] |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | n.a. | 43651.58 | nM | PMID[556267] |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | n.a. | 21183.61 | nM | PMID[556267] |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | n.a. | 32658.78 | nM | PMID[556267] |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | n.a. | 44668.36 | nM | PMID[556267] |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | n.a. | 85901.35 | nM | PMID[556267] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | n.a. | 24547.09 | nM | PMID[556267] |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | n.a. | 36475.39 | nM | PMID[556267] |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | n.a. | 50933.09 | nM | PMID[556267] |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | n.a. | 42364.3 | nM | PMID[556267] |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | n.a. | 31841.98 | nM | PMID[556267] |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | n.a. | 37153.52 | nM | PMID[556267] |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | n.a. | 30619.63 | nM | PMID[556267] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | n.a. | 34514.37 | nM | PMID[556267] |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | n.a. | 26061.54 | nM | PMID[556267] |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | n.a. | 43954.16 | nM | PMID[556267] |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | n.a. | 31550.05 | nM | PMID[556267] |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | n.a. | 51641.64 | nM | PMID[556267] |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | n.a. | 25822.6 | nM | PMID[556267] |
NPT577 | Cell Line | RXF 631 | Homo sapiens | GI50 | n.a. | 39355.01 | nM | PMID[556267] |
NPT534 | Individual Protein | Phosphoglycerate kinase, glycosomal | Trypanosoma brucei brucei | Potency | n.a. | 10000.0 | nM | PMID[556266] |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | n.a. | 49431.07 | nM | PMID[556267] |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | n.a. | 38194.43 | nM | PMID[556267] |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | n.a. | 31477.48 | nM | PMID[556267] |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | n.a. | 34994.52 | nM | PMID[556267] |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | n.a. | 38636.7 | nM | PMID[556267] |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | n.a. | 21677.04 | nM | PMID[556267] |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | n.a. | 33962.53 | nM | PMID[556267] |
NPT100 | Individual Protein | Glutaminase kidney isoform, mitochondrial | Homo sapiens | Potency | n.a. | 17782.8 | nM | PMID[556266] |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | n.a. | 39810.7 | nM | PMID[556266] |
NPT159 | Individual Protein | Aberrant vpr protein | Human immunodeficiency virus 1 | Potency | n.a. | 35481.3 | nM | PMID[556266] |
NPT2953 | Individual Protein | Acyl-CoA synthase | Mycobacterium tuberculosis | AC50 | n.a. | 2730.0 | nM | PMID[556266] |
NPT1417 | Individual Protein | Transcriptional regulator ERG | Homo sapiens | Potency | n.a. | 11220.2 | nM | PMID[556266] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 25929.0 | nM | PMID[556266] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 29092.9 | nM | PMID[556264] |
NPT4015 | Individual Protein | Matrix metalloproteinase 14 | Homo sapiens | IC50 | = | 30600.0 | nM | PMID[556266] |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | n.a. | 891.3 | nM | PMID[556266] |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | n.a. | 75193.0 | nM | PMID[556266] |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | n.a. | 15848.9 | nM | PMID[556264] |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | n.a. | 12589.3 | nM | PMID[556263] |
NPT446 | Individual Protein | Rap guanine nucleotide exchange factor 3 | Homo sapiens | Potency | n.a. | 50118.7 | nM | PMID[556266] |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | n.a. | 18887.6 | nM | PMID[556265] |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | IC50 | = | 2500.0 | nM | PMID[556269] |
NPT582 | Individual Protein | Monoamine oxidase B | Homo sapiens | IC50 | > | 40000.0 | nM | PMID[556269] |
NPT582 | Individual Protein | Monoamine oxidase B | Homo sapiens | Inhibition | = | 23.3 | % | PMID[556269] |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | Activity | = | 36.6 | % | PMID[556269] |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | Activity | = | 55.2 | % | PMID[556269] |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | Activity | = | 54.4 | % | PMID[556269] |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | Activity | = | 63.9 | % | PMID[556269] |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | Ki | = | 422.0 | nM | PMID[556269] |
NPT1604 | Individual Protein | Cytochrome P450 1B1 | Homo sapiens | Ki | = | 700.0 | nM | PMID[556270] |
NPT1604 | Individual Protein | Cytochrome P450 1B1 | Homo sapiens | IC50 | = | 2200.0 | nM | PMID[556270] |
NPT1603 | Individual Protein | Cytochrome P450 1A1 | Homo sapiens | IC50 | = | 5500.0 | nM | PMID[556270] |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | IC50 | = | 2500.0 | nM | PMID[556271] |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | IC50 | = | 2500.0 | nM | PMID[556273] |
NPT582 | Individual Protein | Monoamine oxidase B | Homo sapiens | IC50 | > | 40000.0 | nM | PMID[556273] |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 21872.4 | nM | PubChem BioAssay data set |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 10870.7 | nM | PubChem BioAssay data set |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | n.a. | 48966.2 | nM | PubChem BioAssay data set |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | > | 1000.0 | nM | PMID[556261] |
NPT2 | Others | Unspecified | Inhibition | = | 100.0 | % | PMID[556262] | |
NPT2 | Others | Unspecified | Inhibition | = | 54.3 | % | PMID[556262] | |
NPT2 | Others | Unspecified | Inhibition | = | 34.6 | % | PMID[556262] | |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 39810.7 | nM | PMID[556263] |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 25118.9 | nM | PMID[556264] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 7079.5 | nM | PMID[556264] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 25118.9 | nM | PMID[556263] |
NPT792 | Individual Protein | Arachidonate 15-lipoxygenase | Homo sapiens | Potency | = | 5011.9 | nM | PMID[556264] |
NPT792 | Individual Protein | Arachidonate 15-lipoxygenase | Homo sapiens | Potency | = | 6309.6 | nM | PMID[556263] |
NPT791 | Individual Protein | Cruzipain | Trypanosoma cruzi | Potency | = | 28183.8 | nM | PMID[556263] |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 14125.4 | nM | PMID[556263] |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 17782.8 | nM | PMID[556264] |
NPT864 | Individual Protein | Lethal(3)malignant brain tumor-like protein 1 | Homo sapiens | Potency | = | 31622.8 | nM | PMID[556265] |
NPT2 | Others | Unspecified | Potency | = | 15848.9 | nM | PMID[556263] | |
NPT2 | Others | Unspecified | Potency | n.a. | 12995.3 | nM | PMID[556266] | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | n.a. | 79432.8 | nM | PMID[556266] |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | n.a. | 63095.7 | nM | PMID[556266] |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[556266] |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | n.a. | 26854.5 | nM | PMID[556266] |
NPT821 | Individual Protein | Werner syndrome ATP-dependent helicase | Homo sapiens | Potency | n.a. | 50118.7 | nM | PMID[556266] |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | n.a. | 50118.7 | nM | PMID[556266] |
NPT755 | Individual Protein | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens | Potency | n.a. | 6012.0 | nM | PMID[556266] |
NPT2 | Others | Unspecified | Potency | n.a. | 14581.0 | nM | PMID[556266] | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | n.a. | 9200.0 | nM | PMID[556266] |
NPT2 | Others | Unspecified | IC50 | > | 80000.0 | nM | PMID[556266] | |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 100.09 | % | PMID[556268] |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 98.68 | % | PMID[556268] |
NPT2 | Others | Unspecified | Potency | n.a. | 11220.2 | nM | PMID[556266] | |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | n.a. | 42561.5 | nM | PMID[556266] |
NPT831 | Individual Protein | Serine/threonine-protein kinase PLK1 | Homo sapiens | Potency | n.a. | 26679.5 | nM | PMID[556266] |
NPT2 | Others | Unspecified | Potency | n.a. | 10000.0 | nM | PMID[556266] | |
NPT2 | Others | Unspecified | Potency | n.a. | 22387.2 | nM | PMID[556264] | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | n.a. | 37933.0 | nM | PMID[556266] |
NPT2 | Others | Unspecified | Ratio IC50 | > | 16.0 | n.a. | PMID[556269] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 2.5 | n.a. | PMID[556270] | |
NPT21773 | SINGLE PROTEIN | Thiosulfate sulfurtransferase | Homo sapiens | IC50 | = | 2300.0 | nM | PMID[556272] |
NPT2 | Others | Unspecified | IC50 | > | 63000.0 | nM | PMID[556272] | |
NPT21772 | PROTEIN COMPLEX | GroEL/GroES | Escherichia coli | IC50 | = | 4000.0 | nM | PMID[556272] |
NPT21772 | PROTEIN COMPLEX | GroEL/GroES | Escherichia coli | IC50 | = | 15000.0 | nM | PMID[556272] |
NPT21774 | PROTEIN COMPLEX | HSP60/HSP10 | Homo sapiens | IC50 | = | 23000.0 | nM | PMID[556272] |
NPT21775 | SINGLE PROTEIN | 60 kDa chaperonin | Escherichia coli (strain K12) | IC50 | > | 250000.0 | nM | PMID[556272] |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1.0 | n.a. | PMID[556272] | |
NPT21772 | PROTEIN COMPLEX | GroEL/GroES | Escherichia coli | Inhibition | = | 87.0 | % | PMID[556272] |
NPT21772 | PROTEIN COMPLEX | GroEL/GroES | Escherichia coli | Inhibition | = | 94.0 | % | PMID[556272] |
NPT2 | Others | Unspecified | Potency | n.a. | 61130.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 24336.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 54482.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 27306 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 30637.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 10870.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 15355.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 691.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 68589.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 19493.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 50118.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 48557.7 | nM | PubChem BioAssay data set |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC238629 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9779 | High Similarity | NPC203063 |
0.9559 | High Similarity | NPC147418 |
0.9338 | High Similarity | NPC44437 |
0.9281 | High Similarity | NPC143438 |
0.9265 | High Similarity | NPC294226 |
0.9236 | High Similarity | NPC471907 |
0.9209 | High Similarity | NPC416 |
0.9209 | High Similarity | NPC61398 |
0.9191 | High Similarity | NPC135801 |
0.9137 | High Similarity | NPC290030 |
0.9137 | High Similarity | NPC53414 |
0.9137 | High Similarity | NPC53206 |
0.9118 | High Similarity | NPC469526 |
0.9118 | High Similarity | NPC34070 |
0.9071 | High Similarity | NPC123714 |
0.9065 | High Similarity | NPC254847 |
0.9044 | High Similarity | NPC26697 |
0.9044 | High Similarity | NPC233056 |
0.9007 | High Similarity | NPC138099 |
0.9007 | High Similarity | NPC190457 |
0.9007 | High Similarity | NPC242994 |
0.9007 | High Similarity | NPC472903 |
0.9 | High Similarity | NPC471905 |
0.8993 | High Similarity | NPC129752 |
0.8993 | High Similarity | NPC258502 |
0.8986 | High Similarity | NPC312338 |
0.8986 | High Similarity | NPC149889 |
0.8958 | High Similarity | NPC244691 |
0.8947 | High Similarity | NPC311740 |
0.8944 | High Similarity | NPC181560 |
0.8944 | High Similarity | NPC169452 |
0.8929 | High Similarity | NPC65005 |
0.8929 | High Similarity | NPC194764 |
0.8929 | High Similarity | NPC264112 |
0.8897 | High Similarity | NPC234175 |
0.8882 | High Similarity | NPC84571 |
0.8881 | High Similarity | NPC290550 |
0.8881 | High Similarity | NPC472904 |
0.8857 | High Similarity | NPC14377 |
0.8851 | High Similarity | NPC280295 |
0.8851 | High Similarity | NPC48949 |
0.8849 | High Similarity | NPC267205 |
0.8824 | High Similarity | NPC107672 |
0.8819 | High Similarity | NPC193555 |
0.8819 | High Similarity | NPC291078 |
0.8819 | High Similarity | NPC73061 |
0.8803 | High Similarity | NPC175552 |
0.88 | High Similarity | NPC107109 |
0.8794 | High Similarity | NPC223836 |
0.8792 | High Similarity | NPC35 |
0.8786 | High Similarity | NPC282780 |
0.8786 | High Similarity | NPC166480 |
0.8768 | High Similarity | NPC244441 |
0.8768 | High Similarity | NPC117609 |
0.875 | High Similarity | NPC246638 |
0.875 | High Similarity | NPC92079 |
0.875 | High Similarity | NPC204045 |
0.875 | High Similarity | NPC305845 |
0.875 | High Similarity | NPC8745 |
0.875 | High Similarity | NPC178976 |
0.875 | High Similarity | NPC96915 |
0.8723 | High Similarity | NPC72918 |
0.8716 | High Similarity | NPC218490 |
0.871 | High Similarity | NPC101769 |
0.8707 | High Similarity | NPC476535 |
0.8705 | High Similarity | NPC205992 |
0.8699 | High Similarity | NPC193703 |
0.8699 | High Similarity | NPC471906 |
0.8699 | High Similarity | NPC21599 |
0.8696 | High Similarity | NPC99731 |
0.869 | High Similarity | NPC135524 |
0.8684 | High Similarity | NPC77807 |
0.8684 | High Similarity | NPC14561 |
0.8684 | High Similarity | NPC5379 |
0.8676 | High Similarity | NPC103540 |
0.8676 | High Similarity | NPC10926 |
0.8667 | High Similarity | NPC202157 |
0.8662 | High Similarity | NPC191976 |
0.8627 | High Similarity | NPC199463 |
0.8627 | High Similarity | NPC37543 |
0.8621 | High Similarity | NPC187843 |
0.8603 | High Similarity | NPC13238 |
0.8601 | High Similarity | NPC170742 |
0.86 | High Similarity | NPC294646 |
0.86 | High Similarity | NPC10467 |
0.8592 | High Similarity | NPC161632 |
0.8591 | High Similarity | NPC118726 |
0.8591 | High Similarity | NPC194856 |
0.8591 | High Similarity | NPC287395 |
0.8591 | High Similarity | NPC183655 |
0.8591 | High Similarity | NPC12367 |
0.8591 | High Similarity | NPC276930 |
0.8582 | High Similarity | NPC52407 |
0.8571 | High Similarity | NPC19896 |
0.8571 | High Similarity | NPC48762 |
0.8571 | High Similarity | NPC10764 |
0.8571 | High Similarity | NPC257025 |
0.8562 | High Similarity | NPC142339 |
0.8562 | High Similarity | NPC474961 |
0.8562 | High Similarity | NPC137649 |
0.8561 | High Similarity | NPC92624 |
0.8553 | High Similarity | NPC89474 |
0.8543 | High Similarity | NPC251110 |
0.8543 | High Similarity | NPC78505 |
0.8535 | High Similarity | NPC26386 |
0.8533 | High Similarity | NPC134293 |
0.8529 | High Similarity | NPC375356 |
0.8526 | High Similarity | NPC470694 |
0.8526 | High Similarity | NPC329760 |
0.8523 | High Similarity | NPC239312 |
0.8523 | High Similarity | NPC37709 |
0.8523 | High Similarity | NPC130230 |
0.8523 | High Similarity | NPC275772 |
0.8523 | High Similarity | NPC476463 |
0.8523 | High Similarity | NPC207729 |
0.8516 | High Similarity | NPC119224 |
0.8516 | High Similarity | NPC235018 |
0.8516 | High Similarity | NPC45146 |
0.8514 | High Similarity | NPC34482 |
0.8514 | High Similarity | NPC160777 |
0.8514 | High Similarity | NPC73416 |
0.8511 | High Similarity | NPC175738 |
0.8511 | High Similarity | NPC70622 |
0.8506 | High Similarity | NPC236796 |
0.8503 | High Similarity | NPC287722 |
0.85 | High Similarity | NPC147757 |
0.85 | High Similarity | NPC259942 |
0.8497 | Intermediate Similarity | NPC39184 |
0.8497 | Intermediate Similarity | NPC472048 |
0.8491 | Intermediate Similarity | NPC165979 |
0.8491 | Intermediate Similarity | NPC163130 |
0.8489 | Intermediate Similarity | NPC282923 |
0.8489 | Intermediate Similarity | NPC179898 |
0.8487 | Intermediate Similarity | NPC291802 |
0.8487 | Intermediate Similarity | NPC181209 |
0.8487 | Intermediate Similarity | NPC245382 |
0.8487 | Intermediate Similarity | NPC209487 |
0.8487 | Intermediate Similarity | NPC131266 |
0.8487 | Intermediate Similarity | NPC121522 |
0.8487 | Intermediate Similarity | NPC216769 |
0.8487 | Intermediate Similarity | NPC35763 |
0.8487 | Intermediate Similarity | NPC100971 |
0.8487 | Intermediate Similarity | NPC269451 |
0.8487 | Intermediate Similarity | NPC100263 |
0.8477 | Intermediate Similarity | NPC248102 |
0.8477 | Intermediate Similarity | NPC476532 |
0.8477 | Intermediate Similarity | NPC61620 |
0.8477 | Intermediate Similarity | NPC45873 |
0.8477 | Intermediate Similarity | NPC62042 |
0.8477 | Intermediate Similarity | NPC85131 |
0.8471 | Intermediate Similarity | NPC207690 |
0.8462 | Intermediate Similarity | NPC32694 |
0.8456 | Intermediate Similarity | NPC91478 |
0.8456 | Intermediate Similarity | NPC32032 |
0.8456 | Intermediate Similarity | NPC133909 |
0.8456 | Intermediate Similarity | NPC470570 |
0.8456 | Intermediate Similarity | NPC300274 |
0.8452 | Intermediate Similarity | NPC185258 |
0.8452 | Intermediate Similarity | NPC172770 |
0.8452 | Intermediate Similarity | NPC100123 |
0.8446 | Intermediate Similarity | NPC242893 |
0.8446 | Intermediate Similarity | NPC38065 |
0.8442 | Intermediate Similarity | NPC470762 |
0.8442 | Intermediate Similarity | NPC474167 |
0.8442 | Intermediate Similarity | NPC274730 |
0.844 | Intermediate Similarity | NPC93015 |
0.8431 | Intermediate Similarity | NPC206238 |
0.8431 | Intermediate Similarity | NPC292214 |
0.8431 | Intermediate Similarity | NPC93552 |
0.8431 | Intermediate Similarity | NPC167091 |
0.8431 | Intermediate Similarity | NPC124714 |
0.8431 | Intermediate Similarity | NPC88645 |
0.8431 | Intermediate Similarity | NPC271779 |
0.8428 | Intermediate Similarity | NPC234331 |
0.8428 | Intermediate Similarity | NPC107009 |
0.8425 | Intermediate Similarity | NPC183345 |
0.8421 | Intermediate Similarity | NPC473201 |
0.8421 | Intermediate Similarity | NPC302783 |
0.8421 | Intermediate Similarity | NPC45291 |
0.8421 | Intermediate Similarity | NPC118427 |
0.8421 | Intermediate Similarity | NPC19980 |
0.8421 | Intermediate Similarity | NPC204515 |
0.8421 | Intermediate Similarity | NPC227485 |
0.8417 | Intermediate Similarity | NPC214620 |
0.8414 | Intermediate Similarity | NPC13715 |
0.8414 | Intermediate Similarity | NPC4214 |
0.8414 | Intermediate Similarity | NPC206207 |
0.8411 | Intermediate Similarity | NPC296197 |
0.8411 | Intermediate Similarity | NPC216318 |
0.8411 | Intermediate Similarity | NPC102003 |
0.8411 | Intermediate Similarity | NPC17286 |
0.8411 | Intermediate Similarity | NPC259713 |
0.8411 | Intermediate Similarity | NPC195351 |
0.8411 | Intermediate Similarity | NPC92722 |
0.8408 | Intermediate Similarity | NPC294965 |
0.8403 | Intermediate Similarity | NPC155211 |
0.8403 | Intermediate Similarity | NPC272268 |
0.8403 | Intermediate Similarity | NPC474813 |
0.8403 | Intermediate Similarity | NPC118919 |
0.84 | Intermediate Similarity | NPC190648 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC238629 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9191 | High Similarity | NPD943 | Approved |
0.9065 | High Similarity | NPD1509 | Clinical (unspecified phase) |
0.8929 | High Similarity | NPD651 | Clinical (unspecified phase) |
0.8676 | High Similarity | NPD1470 | Approved |
0.8382 | Intermediate Similarity | NPD1201 | Approved |
0.8322 | Intermediate Similarity | NPD7390 | Discontinued |
0.8322 | Intermediate Similarity | NPD1511 | Approved |
0.8212 | Intermediate Similarity | NPD1512 | Approved |
0.8194 | Intermediate Similarity | NPD2801 | Approved |
0.8176 | Intermediate Similarity | NPD6232 | Discontinued |
0.8137 | Intermediate Similarity | NPD7473 | Discontinued |
0.8077 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8058 | Intermediate Similarity | NPD9269 | Phase 2 |
0.8026 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.8013 | Intermediate Similarity | NPD1934 | Approved |
0.7973 | Intermediate Similarity | NPD5404 | Approved |
0.7973 | Intermediate Similarity | NPD5406 | Approved |
0.7973 | Intermediate Similarity | NPD5405 | Approved |
0.7973 | Intermediate Similarity | NPD5408 | Approved |
0.7905 | Intermediate Similarity | NPD1510 | Phase 2 |
0.781 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.777 | Intermediate Similarity | NPD1607 | Approved |
0.777 | Intermediate Similarity | NPD9268 | Approved |
0.7755 | Intermediate Similarity | NPD1240 | Approved |
0.775 | Intermediate Similarity | NPD3882 | Suspended |
0.7736 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7703 | Intermediate Similarity | NPD230 | Phase 1 |
0.7662 | Intermediate Similarity | NPD3300 | Phase 2 |
0.7658 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7651 | Intermediate Similarity | NPD3818 | Discontinued |
0.764 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7636 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7636 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7636 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7632 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7607 | Intermediate Similarity | NPD5494 | Approved |
0.7605 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7566 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7566 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7564 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7517 | Intermediate Similarity | NPD1164 | Approved |
0.7516 | Intermediate Similarity | NPD7819 | Suspended |
0.7516 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD2935 | Discontinued |
0.7485 | Intermediate Similarity | NPD3749 | Approved |
0.7484 | Intermediate Similarity | NPD3226 | Approved |
0.7455 | Intermediate Similarity | NPD6959 | Discontinued |
0.7452 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7427 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7419 | Intermediate Similarity | NPD3750 | Approved |
0.7372 | Intermediate Similarity | NPD6190 | Approved |
0.7371 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7362 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7353 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7342 | Intermediate Similarity | NPD2534 | Approved |
0.7342 | Intermediate Similarity | NPD2532 | Approved |
0.7342 | Intermediate Similarity | NPD2533 | Approved |
0.7294 | Intermediate Similarity | NPD7054 | Approved |
0.7288 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD7075 | Discontinued |
0.7273 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7267 | Intermediate Similarity | NPD3764 | Approved |
0.7256 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7251 | Intermediate Similarity | NPD7472 | Approved |
0.7246 | Intermediate Similarity | NPD1247 | Approved |
0.7226 | Intermediate Similarity | NPD2346 | Discontinued |
0.7209 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7209 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7195 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7178 | Intermediate Similarity | NPD7411 | Suspended |
0.7168 | Intermediate Similarity | NPD7251 | Discontinued |
0.7161 | Intermediate Similarity | NPD2796 | Approved |
0.7159 | Intermediate Similarity | NPD8150 | Discontinued |
0.7152 | Intermediate Similarity | NPD5402 | Approved |
0.7135 | Intermediate Similarity | NPD3751 | Discontinued |
0.7134 | Intermediate Similarity | NPD2800 | Approved |
0.7133 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7126 | Intermediate Similarity | NPD6234 | Discontinued |
0.7117 | Intermediate Similarity | NPD6599 | Discontinued |
0.7115 | Intermediate Similarity | NPD2344 | Approved |
0.7111 | Intermediate Similarity | NPD6534 | Approved |
0.7111 | Intermediate Similarity | NPD6535 | Approved |
0.7103 | Intermediate Similarity | NPD3019 | Approved |
0.7097 | Intermediate Similarity | NPD3748 | Approved |
0.7097 | Intermediate Similarity | NPD3299 | Clinical (unspecified phase) |
0.7089 | Intermediate Similarity | NPD8166 | Discontinued |
0.7067 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD6799 | Approved |
0.7059 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7051 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7037 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.703 | Intermediate Similarity | NPD6801 | Discontinued |
0.703 | Intermediate Similarity | NPD37 | Approved |
0.7029 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7018 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7013 | Intermediate Similarity | NPD447 | Suspended |
0.7011 | Intermediate Similarity | NPD6778 | Approved |
0.7011 | Intermediate Similarity | NPD6776 | Approved |
0.7011 | Intermediate Similarity | NPD6782 | Approved |
0.7011 | Intermediate Similarity | NPD6780 | Approved |
0.7011 | Intermediate Similarity | NPD6777 | Approved |
0.7011 | Intermediate Similarity | NPD6779 | Approved |
0.7011 | Intermediate Similarity | NPD6781 | Approved |
0.7006 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7006 | Intermediate Similarity | NPD7768 | Phase 2 |
0.6995 | Remote Similarity | NPD7699 | Phase 2 |
0.6995 | Remote Similarity | NPD7700 | Phase 2 |
0.6986 | Remote Similarity | NPD2932 | Approved |
0.6981 | Remote Similarity | NPD1878 | Clinical (unspecified phase) |
0.6978 | Remote Similarity | NPD74 | Approved |
0.6978 | Remote Similarity | NPD9266 | Approved |
0.6971 | Remote Similarity | NPD6559 | Discontinued |
0.6954 | Remote Similarity | NPD9494 | Approved |
0.6948 | Remote Similarity | NPD1612 | Clinical (unspecified phase) |
0.6948 | Remote Similarity | NPD1613 | Approved |
0.6937 | Remote Similarity | NPD2309 | Approved |
0.6929 | Remote Similarity | NPD3021 | Approved |
0.6929 | Remote Similarity | NPD3022 | Approved |
0.6928 | Remote Similarity | NPD2313 | Discontinued |
0.6923 | Remote Similarity | NPD919 | Approved |
0.6919 | Remote Similarity | NPD7501 | Clinical (unspecified phase) |
0.6918 | Remote Similarity | NPD4196 | Clinical (unspecified phase) |
0.6906 | Remote Similarity | NPD9265 | Clinical (unspecified phase) |
0.6906 | Remote Similarity | NPD9264 | Approved |
0.6906 | Remote Similarity | NPD9267 | Approved |
0.6906 | Remote Similarity | NPD9263 | Approved |
0.6905 | Remote Similarity | NPD4967 | Phase 2 |
0.6905 | Remote Similarity | NPD4965 | Approved |
0.6905 | Remote Similarity | NPD4966 | Approved |
0.6899 | Remote Similarity | NPD1471 | Phase 3 |
0.6898 | Remote Similarity | NPD7435 | Discontinued |
0.6897 | Remote Similarity | NPD7804 | Clinical (unspecified phase) |
0.6897 | Remote Similarity | NPD6020 | Phase 2 |
0.6879 | Remote Similarity | NPD2799 | Discontinued |
0.6868 | Remote Similarity | NPD6214 | Clinical (unspecified phase) |
0.6868 | Remote Similarity | NPD6212 | Phase 3 |
0.6868 | Remote Similarity | NPD6213 | Phase 3 |
0.6839 | Remote Similarity | NPD7228 | Approved |
0.6838 | Remote Similarity | NPD1242 | Phase 1 |
0.6835 | Remote Similarity | NPD6099 | Approved |
0.6835 | Remote Similarity | NPD6100 | Approved |
0.6829 | Remote Similarity | NPD920 | Approved |
0.6828 | Remote Similarity | NPD9493 | Approved |
0.6821 | Remote Similarity | NPD1203 | Approved |
0.6813 | Remote Similarity | NPD7421 | Clinical (unspecified phase) |
0.6813 | Remote Similarity | NPD1243 | Approved |
0.681 | Remote Similarity | NPD642 | Clinical (unspecified phase) |
0.6809 | Remote Similarity | NPD7697 | Approved |
0.6809 | Remote Similarity | NPD7696 | Phase 3 |
0.6809 | Remote Similarity | NPD7698 | Approved |
0.6806 | Remote Similarity | NPD8151 | Discontinued |
0.6802 | Remote Similarity | NPD3787 | Discontinued |
0.6802 | Remote Similarity | NPD5711 | Approved |
0.6802 | Remote Similarity | NPD5710 | Approved |
0.6798 | Remote Similarity | NPD8313 | Approved |
0.6798 | Remote Similarity | NPD8312 | Approved |
0.678 | Remote Similarity | NPD5029 | Approved |
0.678 | Remote Similarity | NPD5031 | Approved |
0.678 | Remote Similarity | NPD5027 | Approved |
0.6776 | Remote Similarity | NPD2798 | Approved |
0.6772 | Remote Similarity | NPD7870 | Phase 2 |
0.6772 | Remote Similarity | NPD7871 | Phase 2 |
0.6754 | Remote Similarity | NPD7701 | Phase 2 |
0.6753 | Remote Similarity | NPD3027 | Phase 3 |
0.6752 | Remote Similarity | NPD6651 | Approved |
0.6744 | Remote Similarity | NPD7199 | Phase 2 |
0.6742 | Remote Similarity | NPD5026 | Approved |
0.6742 | Remote Similarity | NPD5034 | Approved |
0.6742 | Remote Similarity | NPD36 | Approved |
0.6742 | Remote Similarity | NPD4955 | Approved |
0.6742 | Remote Similarity | NPD5028 | Approved |
0.6742 | Remote Similarity | NPD4954 | Approved |
0.6727 | Remote Similarity | NPD5403 | Approved |
0.6723 | Remote Similarity | NPD5953 | Discontinued |
0.6711 | Remote Similarity | NPD3026 | Approved |
0.6711 | Remote Similarity | NPD3023 | Approved |
0.6707 | Remote Similarity | NPD5401 | Approved |
0.669 | Remote Similarity | NPD4750 | Phase 3 |
0.669 | Remote Similarity | NPD9281 | Approved |
0.6689 | Remote Similarity | NPD4379 | Clinical (unspecified phase) |
0.6689 | Remote Similarity | NPD3024 | Approved |
0.6689 | Remote Similarity | NPD3025 | Approved |
0.6687 | Remote Similarity | NPD643 | Clinical (unspecified phase) |
0.6685 | Remote Similarity | NPD5037 | Approved |
0.6685 | Remote Similarity | NPD5030 | Phase 2 |
0.6685 | Remote Similarity | NPD8434 | Phase 2 |
0.6685 | Remote Similarity | NPD5038 | Approved |
0.6684 | Remote Similarity | NPD8320 | Phase 1 |
0.6684 | Remote Similarity | NPD8319 | Approved |
0.6684 | Remote Similarity | NPD7874 | Approved |
0.6684 | Remote Similarity | NPD7875 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD7003 | Approved |
0.6667 | Remote Similarity | NPD846 | Approved |
0.6667 | Remote Similarity | NPD6823 | Phase 2 |
0.6667 | Remote Similarity | NPD2342 | Discontinued |
0.6667 | Remote Similarity | NPD4628 | Phase 3 |
0.6667 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD7635 | Approved |
0.6667 | Remote Similarity | NPD940 | Approved |
0.6667 | Remote Similarity | NPD7184 | Clinical (unspecified phase) |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.